Sondex PLC
21 September 2007
Amendment to 8.1 released 20 September 2007
FORM 8.1
DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES
FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
(Rules 8.1(a) and (b)(i) of the Takeover Code)
1. KEY INFORMATION
Name of person dealing (Note 1) Christopher Wilks
Company dealt in Sondex plc
Class of relevant security to which the dealings being Ordinary shares of 10
disclosed relate (Note 2) pence each
Date of dealing 17 September 2007
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 734571 1.3%
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total 734571 1.3%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
(c) Rights to subscribe (Note 3)
Class of relevant security: Details
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note 5)
Purchase
(b) Derivatives transactions (other than options)
Product Long/short (Note Number of securities (Note Price per unit (Note
name, 6) 7) 5)
e.g. CFD
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, e.g. Expiry Option money
name, selling, securities price American, date paid/
e.g. purchasing, to which European received
call varying etc. the option etc. per unit
option relates (Note 5)
(Note 7)
(ii) Exercising
Product name, e.g. call Number of Exercise price per unit (Note
option securities 5)
Options granted
under the Sondex
Sharesave Scheme 6003 157 pence sterling
(d) Other dealings (including new securities) (Note 4)
Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5)
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be
stated.
Options granted under the Sondex Sharesave scheme (approved by shareholders on
23 June 2004)
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 17 September 2007
Contact name Christopher Wilks
Telephone number 01252 862 200
Name of offeree/offeror with which associated Sondex plc
Specify category and nature of associate status (Note 10) Offeree
Notes
The Notes on Form 8.1 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.